Kinesiophobia in Women With Stress Urinary Incontinence

NCT ID: NCT07330739

Last Updated: 2026-01-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

112 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-11-20

Study Completion Date

2026-02-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

All women included in the study will be administered the Causes of Kinesiophobia Scale (KCS), the International Physical Activity Questionnaire (Short), the International Incontinence Consultation Questionnaire-Short Form (ICIQ-SF), and the Pittsburgh Sleep Quality Questionnaire (PSQI). Subsequent analysis will determine the causes of kinesiophobia in women with urinary incontinence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All women included in the study will be administered the Causes of Kinesiophobia Scale (KCS), the International Physical Activity Questionnaire (Short), the International Incontinence Consultation Questionnaire-Short Form (ICIQ-SF), and the Pittsburgh Sleep Quality Questionnaire (PSQI). Subsequent analysis will determine the causes of kinesiophobia in women with urinary incontinence. The results will then be compared with those of healthy women.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Kinesiophobia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Stress Urinary Incontinence

Survey

Intervention Type OTHER

survey

Control

Survey

Intervention Type OTHER

survey

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Survey

survey

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Being between 18-65 years old
2. Having stress urinary incontinence
3. Voluntary participation in the study

Exclusion Criteria

1. Unwillingness to continue working
2. Presence of neurological or orthopedic disease
3. Learning disability or other cognitive impairments.
Minimum Eligible Age

18 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Esra BAYRAMOĞLU DEMİRDÖĞEN

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Esra BAYRAMOĞLU DEMİRDÖĞEN

LECTURER DOCTOR

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

ESRA bayramoğlu demirdöğen

Role: PRINCIPAL_INVESTIGATOR

Kirsehir Ahi Evran Universitesi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Kirşehir Ahi Evran University Physical Therapy and Rehabilitation Hospital

Kırşehir, Centre, Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

KAEU-EBAYRAMOGLUD-005

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.